SETD2-H3K36ME3: an important bridge between the environment and tumors

Front Genet. 2023 Jun 9:14:1204463. doi: 10.3389/fgene.2023.1204463. eCollection 2023.

Abstract

Epigenetic regulation plays an important role in the occurrence, development and treatment of tumors. The histone methyltransferase SET-domain-containing 2 (SETD2) plays a key role in mammalian epigenetic regulation by catalyzing histone methylation and interacting with RNA polymerase II to mediate transcription elongation and mismatch repair. As an important bridge between the environment and tumors, SETD2-H3K36me3 plays an important role in the occurrence and development of tumors. Many tumors, including renal cancer, gastric cancer, lung cancer, are closely related to SETD2 gene mutations. As a key component of common tumor suppressor mechanisms, SETD2-H3K36me3is an important target for clinical disease diagnosis and treatment. Here, we reviewed the structure and function of the SETD2 and how SETD2-H3K36me3 functions as a bridge between the environment and tumors to provide an in-depth understanding of its role in the occurrence and development of various tumors, which is of great significance for future disease diagnosis and treatment.

Keywords: SETD2 H3K36me3; environment; epigenetic drug; epigenetics; tumor.

Publication types

  • Review

Grants and funding

This study was supported by the following grants: the National Key Research and Development Plan of China (2020YFC2006000) and National Natural Science Foundation of China (81670144).